Picture of Aethlon Medical logo

AEMD — Aethlon Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Aethlon Medical Receives Second Ethics Committee Approval For Hemopurifier® Cancer Trial

Aug 12 (Reuters) - Aethlon Medical Inc  AEMD.O :
    * AETHLON MEDICAL RECEIVES SECOND ETHICS COMMITTEE APPROVAL
FOR
HEMOPURIFIER® CANCER TRIAL
    * APPROVAL IS VALID FOR ONE YEAR, UNTIL AUGUST 6, 2025

Source text for Eikon:  ID:nPn8bTfRra 
Further company coverage:  AEMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aethlon Medical

See all news